FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

41419611000001107: Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Feb 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2604291000001115 Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2604301000001116 Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Product containing precisely valganciclovir (as valganciclovir hydrochloride) 450 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Valganciclovir true Inferred relationship Existential restriction modifier
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has specific active ingredient Valganciclovir hydrochloride true Inferred relationship Existential restriction modifier
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Valganciclovir 450mg tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) 60 tablet Has AMP True Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start